Nucleai
Byron Lawson is a seasoned executive in the field of pharmaceutical business development, currently serving as Vice President of Pharma Business Development at Nucleai since April 2025. In this role, Byron focuses on forging strategic partnerships and collaborations within the pharmaceutical and biotech sectors to advance AI-powered biomarker discovery and clinical trial initiatives. Prior experience includes a tenure as Senior Director at Exact Sciences, where Byron led cross-functional teams in precision oncology solutions, and as Senior Vice President and Chief Commercial Officer at HTG Molecular Diagnostics, overseeing all commercial operations and driving revenue growth. Byron began a career in business management at Ventana Medical Systems and has foundational experience from service in the United States Air Force, contributing to a diverse skill set in medical administration and histopathology.
This person is not in any teams
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.